If Medivation Is Sold, Brean Thinks It'll Be For Far More Than Sanofi's Bid
May 06, 2016 at 10:29 AM EDT
Medivation Inc (NASDAQ: MDVN) reported its U.S. and ex-U.S. Xtandi sales for 1Q16 in line with the consensus. Brean Capital’s ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|